Table 4.
Isolate number of patients | AN | CN | TOB | SAM | STX | IPM | MEM | CAZ | CIP | TZP |
1 | R | R | R | R | R | R | R | R | R | R |
2 | R | R | R | R | R | R | R | R | R | R |
3 | R | R | R | R | R | R | R | R | R | R |
4 | R | R | R | R | R | R | R | R | R | R |
5 | R | R | R | R | R | R | R | R | R | R |
6 | R | R | R | R | R | R | R | R | R | R |
7 | R | R | R | R | R | R | R | R | R | R |
8 | R | R | S | R | R | R | R | R | R | R |
9 | R | S | R | R | R | R | R | R | R | R |
10 | R | R | R | R | S | R | R | R | R | R |
11 | R | S | R | R | R | R | R | R | R | R |
12 | R | R | R | R | R | R | R | R | R | R |
13 | R | R | R | R | R | R | R | R | R | R |
14 | R | R | R | R | S | R | R | R | R | R |
15 | R | R | R | R | S | R | R | R | R | R |
16 | R | R | R | R | R | R | R | R | R | R |
CO: Colistin; AN: Amikacin; CN: Gentamicin; TOB: Tobramycin; TE: Tetracycline; IPM: Imipenem; LEV: Levofloxacin; SXT: Trimetoprim-sulfamethoxazole; CIP: Ciprofloxacin; MEM: Meropenem; PIP: Piperacillin; TZP: Piperacillin-tazobactam; FEP: Sefepim; CAZ: Ceftazidim; SAM: Sulbactam-ampicillin; R: Resistant; S: Susceptible.